Leonteq Securities AG’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-300,000
Closed -$18.5M 1318
2022
Q3
$18.5M Buy
+300,000
New +$18.9M 0.72% 31
2022
Q1
Sell
-25,000
Closed -$1.82M 1284
2021
Q4
$1.82M Buy
+25,000
New +$1.72M 0.07% 238

Other funds holding GILD

Leonteq Securities AG's GILD Position: Q2 2026 in Review

Leonteq Securities AG increased its Gilead Sciences (GILD) stake by 53% in Q2 2026, buying an estimated $786K and bringing the position to 17,286 shares worth $2.18M. The position accounts for 0.08% of the portfolio, ranked #172.

Leonteq Securities AG first reported a position in GILD in Q4 2020 and has held it in 18 quarters since. The position peaked at $9.79M in Q4 2020. 965 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Leonteq Securities AG held 17,286 shares of Gilead Sciences worth $2.18M as of Q2 2026.
  • Leonteq Securities AG bought 5,968 Gilead Sciences shares in Q2 2026, an estimated $786K.
  • Gilead Sciences made up 0.08% of Leonteq Securities AG's portfolio in Q2 2026, its #172 holding.
  • Leonteq Securities AG first reported a position in Gilead Sciences in Q4 2020 and has held it in 18 quarters since.
  • Leonteq Securities AG's Gilead Sciences position peaked at $9.79M in Q4 2020.
  • 965 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.